Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEPTOX: Botox vs Vesicare in MS
NCT04819360Phase 4Terminated
- Start
- Jun 2021
- Primary completion
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in Neurogenic Bladder (NB). Started Jun 2021; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
Neurogenic Bladder (NB)
Beyond the preview
Go deeper on NCT04819360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04819360.